Arrowhead Research reported $105.32M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Anika Therapeutics ANIK:US $ 43.04M 2.79M
Arrowhead Research ARWR:US $ 105.32M 4.93M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Cerulean Pharma CERU:US $ 8.4M 1.14M
Heron Therapeutics HRTX:US $ 86.38M 12.19M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
IONIS PHARMACEUT IONS:US $ 199.42M 19.98M
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Merk MRK:US $ 9666M 666M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Moderna Inc MRNA:US 2.3B 463M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Novartis NOVN:VX 10.86B 895M
Opko Health OPK:US $ 320.63M 81.01M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Spectrum Pharmaceuticals SPPI:US $ 14.06M 22.79M
Tg Therapeutics TGTX:US $ 39.53M 29.35M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Xencor XNCR:US $ 58.18M 854K
YTE INCY:US $ 656.97M 40.27M